These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7018458)

  • 21. [Experiment comparative clinical study with three liver trophical substances on some alcoholic not cirrhotic liver disease (author's transl)].
    Buzzi S; Ghetti C; Sala G
    Ateneo Parmense Acta Biomed; 1980; 51(3):129-37. PubMed ID: 7213455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].
    Arrigo A
    Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980
    [No Abstract]   [Full Text] [Related]  

  • 23. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism].
    Busin S; Micheli PL; Sovera A
    Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thiazolidine-carboxylic acid in the ambulatory treatment of chronic hepatopathies].
    Russu G; Lungu I; Boingeanu A
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):585-90. PubMed ID: 4453681
    [No Abstract]   [Full Text] [Related]  

  • 25. Arginine thiazolidinecarboxylate 14C uptake by individual phospholipids isolated from rat liver microsomes.
    Dubini F; Falchi M
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):231-3. PubMed ID: 7251239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of the short-term treatment of active chronic liver diseases with betamethasone].
    Sarti F; Milandri GL; Giuliani Piccari G; Formica G; Spongano P; Accardo P
    G Clin Med; 1982 Jun; 63(6):392-400. PubMed ID: 6816654
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical cases on the use of a combination of substances with hepatoprotective and detoxicant action in the treatment of some acute and chronic liver diseases].
    Ivaldi A
    Minerva Med; 1967 Apr; 58(34 Suppl):1618-20. PubMed ID: 4226049
    [No Abstract]   [Full Text] [Related]  

  • 28. [Action of thiazolidine carboxylic acid in hepatic pathology].
    Dornier R
    Therapeutique; 1968 Nov; 44(9):555-7. PubMed ID: 5759648
    [No Abstract]   [Full Text] [Related]  

  • 29. [The hepato-protective effect of a combination of amino acids of the Krebs-Henseleit cycle. Clinical and statistical considerations].
    Ruberti A; Mirizio A; Accardo G
    Clin Ter; 1969 Sep; 50(5):397-425. PubMed ID: 5382524
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethanol-induced changes in the content of thiol compounds and of lipid peroxidation in livers and brains from mice: protection by thiazolidine derivatives.
    Wlodek L; Rommelspacher H
    Alcohol Alcohol; 1994 Nov; 29(6):649-57. PubMed ID: 7695779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lethality of standard total parenteral nutrition following major liver resection in rats is prevented by high arginine and high branched chain amino acids but not by glutamine.
    Qiu JG; Delany HM; Teh EL; Gliedman ML; Chang CJ; Levenson SM
    J Assoc Acad Minor Phys; 2001 Mar; 12(1-2):109-18. PubMed ID: 11851195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical demonstration of the action of liver drugs].
    Einsiedel-Schömer W
    Z Allgemeinmed; 1973 Oct; 49(30):1452-5. PubMed ID: 4588532
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical considerations on the use of a new preparation with hepatoprotective action].
    Di Lorenzo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1626-9. PubMed ID: 4226051
    [No Abstract]   [Full Text] [Related]  

  • 35. The protective effects of L-arginine after liver ischaemia/reperfusion injury in a pig model.
    Calabrese F; Valente M; Pettenazzo E; Ferraresso M; Burra P; Cadrobbi R; Cardin R; Bacelle L; Parnigotto A; Rigotti P
    J Pathol; 1997 Dec; 183(4):477-85. PubMed ID: 9496266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity of arginine thiazolidin carboxylate on the acute poisoning by paracetamol in mice].
    Pagella PG; Faini D; Turba C
    Boll Chim Farm; 1980 Apr; 119(4):237-40. PubMed ID: 7459046
    [No Abstract]   [Full Text] [Related]  

  • 37. A controlled clinical trial of lactulose in hepatic encephalopathy.
    Simmons F; Goldstein H; Boyle JD
    Gastroenterology; 1970 Dec; 59(6):827-32. PubMed ID: 4922276
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B.
    Honkoop P; de Man RA; Scholte HR; Zondervan PE; Van Den Berg JW; Rademakers LH; Schalm SW
    Hepatology; 1997 Jul; 26(1):211-5. PubMed ID: 9214472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of combined arginine-betaine-sorbitol therapy in the treatment of metabolic liver diseases].
    Abbou R; Mahoudeau D; Dubrisay J; Volteau M
    Sem Hop; 1965 Apr; 41(19):1170-6. PubMed ID: 4284191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.